Torray Investment Partners’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-117,301
| Closed | -$782K | – | 105 |
|
|
2025
Q1 | $782K | Sell |
117,301
-4,794
| -4% | -$32K | 0.12% | 84 |
|
|
2024
Q4 | $1.53M | Buy |
122,095
+48,671
| +66% | +$612K | 0.22% | 76 |
|
|
2024
Q3 | $1.36M | Buy |
73,424
+6,208
| +9% | +$115K | 0.19% | 83 |
|
|
2024
Q2 | $1.45M | Buy |
67,216
+6,283
| +10% | +$135K | 0.22% | 81 |
|
|
2024
Q1 | $1.64M | Buy |
60,933
+77
| +0.1% | +$2.07K | 0.25% | 73 |
|
|
2023
Q4 | $1.82M | Buy |
60,856
+679
| +1% | +$20.4K | 0.3% | 67 |
|
|
2023
Q3 | $1.23M | Buy |
60,177
+5,608
| +10% | +$115K | 0.22% | 81 |
|
|
2023
Q2 | $1.08M | Buy |
54,569
+337
| +0.6% | +$6.7K | 0.19% | 83 |
|
|
2023
Q1 | $929K | Sell |
54,232
-92
| -0.2% | -$1.58K | 0.17% | 90 |
|
|
2022
Q4 | $1.06M | Sell |
54,324
-2,627
| -5% | -$51.4K | 0.19% | 87 |
|
|
2022
Q3 | $909K | Sell |
56,951
-3,524
| -6% | -$56.2K | 0.18% | 89 |
|
|
2022
Q2 | $832K | Buy |
60,475
+16,820
| +39% | +$231K | 0.16% | 93 |
|
|
2022
Q1 | $692K | Buy |
43,655
+7,206
| +20% | +$114K | 0.11% | 96 |
|
|
2021
Q4 | $796K | Sell |
36,449
-1,333
| -4% | -$29.1K | 0.12% | 98 |
|
|
2021
Q3 | $1.13M | Buy |
37,782
+422
| +1% | +$12.6K | 0.17% | 93 |
|
|
2021
Q2 | $1.66M | Buy |
37,360
+8,299
| +29% | +$368K | 0.24% | 87 |
|
|
2021
Q1 | $1.29M | Sell |
29,061
-5,403
| -16% | -$240K | 0.2% | 92 |
|
|
2020
Q4 | $1.89M | Sell |
34,464
-14,331
| -29% | -$786K | 0.31% | 67 |
|
|
2020
Q3 | $1.12M | Buy |
48,795
+218
| +0.4% | +$4.98K | 0.2% | 87 |
|
|
2020
Q2 | $1.02M | Sell |
48,577
-7,881
| -14% | -$165K | 0.19% | 88 |
|
|
2020
Q1 | $788K | Buy |
56,458
+26,400
| +88% | +$368K | 0.17% | 88 |
|
|
2019
Q4 | $684K | Buy |
+30,058
| New | +$684K | 0.12% | 92 |
|